Evaluation of renal markers and liver enzymes in patients infected with the Chikungunya virus
Journal of Medical Virology · 2023-12 · 95 (12)
DOI: 10.1002/jmv.29276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 15.12.2023. Verfasst von Anderson Pereira Soares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, …. Hauptthemen laut MEDLINE: Chikungunya virus, Chikungunya Fever, Arboviruses. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
Chikungunya virus (CHIKV) is an arbovirus ( Togaviridae family, Alphavirus genus) that was first identified in 1953 in Tanzania. In 2014, the Asian and East/Central/South/African (ECSA) genotypes were identified in Brazil, although the genotype that spread the most in the following years across the Brazilian territory was the ECSA. The clinical symptoms associated with the infection caused by CHIKV include mainly fever, myalgia, headache, and arthralgia. In infections caused by other arboviruses (such as the ones caused by Dengue and West Nile viruses), changes in biochemical markers are often observed. This study aims to evaluate the biochemical markers profile of kidney and liver injury in acute patients infected with CHIKV. Two groups of correlations were found between the variables analyzed, namely, one between liver enzymes ( r = 0.91), and another for kidney markers ( r = 0.54–0.66). A significant elevation in the percentage of altered creatinine in CHIKV‐infected patients was observed, followed by uric acid and AST. Altogether, in 8 different comparisons, it was possible to observe statistically significant differences between the levels of the markers when compared to the manifestation of symptoms (presence and absence). These noticeable changes in marker measurements could potentially be connected to the range of clinical symptoms seen in the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo, São Paulo, Brazil.
- Department of Pediatrics, Jundiaí School of Medicine, Jundiaí, São Paulo, Brazil.
ORCID-Profile: Anderson Pereira Soares, Daniel Ferreira de Lima Neto, Shahab Zaki Pour, Saulo Duarte Passos, Marielton Dos Passos Cunha, Paolo Marinho de Andrade Zanotto
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Soares, A. P., de Lima Neto, D. F., Pour, S. Z., Passos, S. D., Cunha, M. D. P., & Zanotto, P. M. A. (2023). Evaluation of renal markers and liver enzymes in patients infected with the Chikungunya virus. Journal of Medical Virology, 95(12). https://doi.org/10.1002/jmv.29276
Vancouver
Soares AP, de Lima Neto DF, Pour SZ, Passos SD, Cunha MDP, Zanotto PMA. Evaluation of renal markers and liver enzymes in patients infected with the Chikungunya virus. Journal of Medical Virology. 2023;95(12). doi:10.1002/jmv.29276
BibTeX
@article{Soares2023,
author = {Soares, Anderson Pereira and de Lima Neto, Daniel Ferreira and Pour, Shahab Zaki and Passos, Saulo Duarte and Cunha, Marielton Dos Passos and Zanotto, Paolo Marinho de Andrade},
title = {Evaluation of renal markers and liver enzymes in patients infected with the Chikungunya virus},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {12},
doi = {10.1002/jmv.29276}
}
EUVIMED